Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H23NO5 |
Molecular Weight | 345.3896 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C(O)C=CC4=C3[C@@]15CCN(CCOC)[C@H](C4)[C@]5(O)CCC2=O
InChI
InChIKey=PBGIBLLOMGURPS-GRGSLBFTSA-N
InChI=1S/C19H23NO5/c1-24-9-8-20-7-6-18-15-11-2-3-12(21)16(15)25-17(18)13(22)4-5-19(18,23)14(20)10-11/h2-3,14,17,21,23H,4-10H2,1H3/t14-,17+,18+,19-/m1/s1
Molecular Formula | C19H23NO5 |
Molecular Weight | 345.3896 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7957512
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7957512
Semorphone (previously known as Mr 2264), a partial opiate receptor agonist that was in two times more potent than morphine. Semorphone has a ceiling effect on both analgesia and respiratory depression; it means that these effects stop becoming any stronger after a certain maximum dose.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7957512
M(r) 2264 Cl (SEMORPHONE) 2 x 5 mg i.v.,
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:56:53 GMT 2023
by
admin
on
Fri Dec 15 15:56:53 GMT 2023
|
Record UNII |
2HD55617I2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C76846
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
2HD55617I2
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
DTXSID00933465
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
Semorphone
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
100000084110
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107565
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
6951
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
5491906
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
SUB10480MIG
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
88939-40-6
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->PARTIAL AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|